EdgeMarketInstruments › LQDA

LQDA — Liquidia Corp

US Healthcare Pharma & biotech equity mkt cap 6.1B
68.62 -3.46% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 21.80 · high 91.03

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-07-26.

Performance

1 day-3.46%
1 week-7.82%
1 month-22.92%
3 months+10.73%
6 months+104.29%
Year to date+118.54%
1 year+150.90%
3 years+891.62%
5 years+2479.70%

Technicals

RSI 1432.2
vs 50-day avg-13.30%
vs 200-day avg+39.30%
Volatility 1y65.6%
Max drawdown 1y-35.66%
Avg volume 30d1.6M
Daily bars held2,029
History from2018-07-26

Measured signals that fired on LQDA

datesignal measured base rate
2026-08-13Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group
2026-08-05Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group
2026-08-05Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-08-05Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-07-23Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group
2026-07-13Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-20Rielly-Gauvin Katherine
Director
Open-market sale 10b5-1 plan18.4K72.231.3M
2026-08-20Rielly-Gauvin Katherine
Director
Option exercise 10b5-1 plan11.7K2.5129.4K
2026-08-20Rielly-Gauvin Katherine
Director
Option exercise 10b5-1 plan6.7K2.5917.3K
2026-08-19Saggar Rajeev
Chief Medical Officer
Open-market sale50.0K74.063.7M
2026-08-19Rielly-Gauvin Katherine
Director
Open-market sale 10b5-1 plan36.8K74.992.8M
2026-08-19Saggar Rajeev
Chief Medical Officer
Option exercise50.0K3.73186.5K
2026-08-19Rielly-Gauvin Katherine
Director
Option exercise 10b5-1 plan23.5K2.5158.9K
2026-08-19Rielly-Gauvin Katherine
Director
Option exercise 10b5-1 plan13.3K2.5934.5K
2026-08-17Saggar Rajeev
Chief Medical Officer
Open-market sale29.5K76.842.3M
2026-07-27Boyle Dana
Chief Accounting Officer
Open-market sale 10b5-1 plan1.6K87.53140.0K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
FARALLON CAPITAL MANAGEMENT LLC326.7M8.7M
Caligan Partners LP306.4M8.1M
BlackRock, Inc.207.2M5.5M
FINDELL CAPITAL MANAGEMENT LLC132.2M3.5M
VANGUARD CAPITAL MANAGEMENT LLC110.5M2.9M
Opaleye Management Inc.88.8M2.5M
BANK OF AMERICA CORP /DE/86.3M2.3M
GEODE CAPITAL MANAGEMENT, LLC72.8M1.9M
STATE STREET CORP71.0M1.9M
MPM BIOIMPACT LLC53.0M1.4M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
42026-08-192026-08-17on EDGAR ↗
1442026-08-19on EDGAR ↗
1442026-08-19on EDGAR ↗
1442026-08-17on EDGAR ↗
SCHEDULE 13G/A2026-08-14on EDGAR ↗
10-Q2026-08-122026-06-30on EDGAR ↗
8-K2026-08-122026-08-12on EDGAR ↗
SCHEDULE 13G/A2026-08-04on EDGAR ↗

Short selling

Avg short volume, 90d63.8% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about LQDA

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open LQDA in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →